LEXINGTON, KY – The results of anti-doping drugs
tests conducted in 2013 by state racing commissions, the United States
Anti-Doping Agency, and the World Anti-Doping Agency are “virtually identical” according to an
analysis of all pertinent testing results.
“The numbers don’t lie,” said Racing
Commissioners International President Ed Martin, noting that U.S. racing
commissions sent 340,932[1] biological samples to a network of
professional drug testing laboratories in 2013.
99.65% of those samples were found to
have no violation.
By comparison, the U.S. Anti-Doping
Agency (USADA) performed 9,197 doping control tests in 2013.[2]
Of the samples tested, approximately 99.55% were determined to have no
violation.[3]
In 2013, testing authorities
reporting to the World Anti-Doping Association (WADA) performed 207,513 drug
tests. Of that testing, 98.97% were found to have no adverse analytical
finding.[4]
“The anti-doping testing effort of
U.S. racing regulators is 60% larger than the entire world wide effort of WADA.
Our program is thirty-seven times larger than the one operated by USADA,” Martin said.
“Drug testing oversight in racing is
performed by government agencies not beholden to anyone but the public. We all
have the same challenge and we are all combatting it the same way and our
results are similar,”
he noted. “All sports have a challenge with those who would deliberately
rely on doping to affect performance. We must continue to be vigilant in
detecting and developing tests for substances that emerge.”
In 2013, racing commissions cited a
total of 1,140 medication rule violations. Of that number, 1.2% (14) were for
the most egregious Class 1 doping substances; 5.9% (68) for Class 2 doping
substances.
The overwhelming majority of
violations - 60.3% (687) - were for overages of Class 4 and 5 substances
considered therapeutic overages and not doping. 32.5% (371) of the violations
were for Class 3 substances.
The following chart is a state by
state breakdown of the results of racing commission drug testing conducted
during 2013:
|
Jurisdiction
|
Drug Tests
|
Violations
|
Adverse Analytical
Finding Rate (%)
|
Clear Rate (%)
|
|
Alabama
|
1,576
|
1
|
0.063
|
99.94
|
|
Arkansas
(Failed to Report)
|
||||
|
Arizona
|
5,518
|
28
|
0.507
|
99.49
|
|
California*
|
26,005
|
89
|
0.342
|
99.66
|
|
Colorado
|
1,176
|
3
|
0.255
|
99.74
|
|
Delaware
Harness
|
4,504
|
3
|
0.067
|
99.93
|
|
Delaware
Thoroughbred
|
1,889
|
8
|
0.424
|
99.58
|
|
Florida*
|
68,317
|
251
|
0.367
|
99.63
|
|
Iowa
|
9,825
|
24
|
0.244
|
99.76
|
|
Idaho
|
363
|
5
|
1.377
|
98.62
|
|
Illinois
|
13,817
|
30
|
0.217
|
99.78
|
|
Indiana
|
8,792
|
5
|
0.057
|
99.94
|
|
Kentucky
|
7,588
|
56
|
0.738
|
99.26
|
|
Louisiana
|
12,806
|
74
|
0.578
|
99.42
|
|
Massachusetts
|
4,805
|
23
|
0.479
|
99.52
|
|
Maryland
|
8,898
|
1
|
0.011
|
99.99
|
|
Michigan
|
1,936
|
20
|
1.033
|
98.97
|
|
Minnesota
|
4,523
|
18
|
0.398
|
99.60
|
|
Montana
|
61
|
3
|
4.918
|
95.08
|
|
North
Dakota
|
106
|
0
|
0.000
|
100.00
|
|
Nebraska
|
970
|
3
|
0.309
|
99.69
|
|
New
Jersey
|
9,611
|
22
|
0.229
|
99.77
|
|
New
Mexico
|
3,061
|
51
|
1.666
|
98.33
|
|
Nevada
|
182
|
1
|
0.549
|
99.45
|
|
New
York
|
53,136
|
67
|
0.126
|
99.87
|
|
Ohio
|
14,311
|
75
|
0.524
|
99.48
|
|
Oklahoma
|
8,308
|
42
|
0.506
|
99.49
|
|
Oregon
|
1,211
|
9
|
0.743
|
99.26
|
|
Pennsylvania
|
32,678
|
52
|
0.159
|
99.84
|
|
South
Dakota
|
132
|
0
|
0.000
|
100.00
|
|
Texas
|
11,010
|
68
|
0.618
|
99.38
|
|
Virginia
|
1555
|
26
|
1.672
|
98.33
|
|
Washington
|
1,179
|
8
|
0.679
|
99.32
|
|
West
Virginia
|
20,923
|
73
|
0.349
|
99.65
|
|
Wyoming
|
160
|
1
|
0.625
|
99.38
|
|
All Jurisdictions
|
340,932
|
1,140
|
0.334
|
99.67
|
|
*
Fiscal Year 2012-2013
|
Comparison of Testing Results
|
|
U.S. Racing
|
USADA
|
WADA Worldwide
|
|
Number of Tests
|
340,932
|
9,197
|
207,513
|
|
Adverse Analytical Findings
(Violations)
|
1,140
|
27 sanctioned + 8 referred + 7
pending
|
2,135
|
|
Clear Rate
|
99.67%
|
99.55%
|
98.97%
|
